Senisca Ltd

Senisca Ltd, based in Exeter, UK, is a small, active company founded four years ago in 2020. Employing ten people and holding £786,649 in assets, it operates from a real address at the Innovation Centre, University of Exeter. With seven directors and no owners reported, the company is a regular importer, primarily of miscellaneous chemical products, with nineteen months of import activity recorded, the last in March 2025.

The company’s website highlights a focus on reversing cell ageing through research and development in biotechnology. Senisca positions itself as an award-winning biotech from the University of Exeter, targeting cellular ageing (senescence) via RNA senotherapeutics. Their scientific approach involves modulating RNA biology to treat age-related diseases, leveraging research into dysregulated RNA splicing as a novel hallmark of ageing. The website details a team of experts, including a Chief Executive, Chief Scientific Officer, and Head of Discovery Research, all contributing to the company’s mission. They even have a board of advisors.

Financially, Senisca Ltd presents a mixed picture. While current assets are substantial, they’ve decreased significantly, dropping 62% to £790,000. Net assets have also taken a hit, falling 66% to £720,000. Cash bank on hand has plummeted 78%, shrinking to £350,000. Creditors have increased dramatically, rising 350% to £320,000—a sign that the company may be relying more on borrowed funds. The number of employees has also increased by 30%, rising to thirteen, which could be a sign of growth, but also increased expenses. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for agility, but the decrease in equity raises questions about its long-term financial health. With no auditor mentioned, the figures rely on unaudited statements.

Overall, Senisca Ltd appears to be a promising biotech company with a unique scientific approach, but its financial performance suggests it's burning through money quickly. Whether it can secure further funding or achieve profitability remains to be seen—but its focus on reversing cell ageing positions it in a rapidly growing field.

Registered in England/Wales under the registration number 12948837, with a registered address at EX4 4RN, England, Exeter, Devon, Innovation Centre University Of Exeter, Rennes Drive.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.